|
1
|
Morton CL and Houghton PJ: Establishment
of human tumor xenografts in immunodeficient mice. Nat Protoc.
2:247–250. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jin K, Li G, Cui B, Zhang J, Lan H, Han N,
Xie B, Cao F, He K, Wang H, et al: Assessment of a novel VEGF
targeted agent using patient-derived tumor tissue xenograft models
of colon carcinoma with lymphatic and hepatic metastases. PLoS One.
6:e283842011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Johnson JI, Decker S, Zaharevitz D,
Rubinstein LV, Venditti JM, Schepartz S, Kalyandrug S, Christian M,
Arbuck S, Hollingshead M, et al: Relationships between drug
activity in NCI preclinical in vitro and in vivo models and early
clinical trials. Br J Cancer. 84:1424–1431. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sausville EA, Burger AM, Becher OJ and
Holland EC: Contributions of human tumor xenografts to anticancer
drug development. Cancer Res. 66:3351–3354. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fujii E, Suzuki M, Matsubara K, Watanabe
M, Chen YJ, Adachi K, Ohnishi Y, Tanigawa M, Tsuchiya M and Tamaoki
N: Establishment and characterization of in vivo human tumor models
in the NOD/SCID/gamma(c)(null) mouse. Pathol Int. 58:559–567. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bertotti A, Migliardi G, Galimi F, Sassi
F, Torti D, Isella C, Corà D, Di Nicolantonio F, Buscarino M, Petti
C, et al: A molecularly annotated platform of patient-derived
xenografts (‘xenopatients’) identifies HER2 as an effective
therapeutic target in cetuximab-resistant colorectal cancer. Cancer
Discov. 1:508–523. 2011. View Article : Google Scholar
|
|
7
|
Galimi F, Torti D, Sassi F, Isella C, Corà
D, Gastaldi S, Ribero D, Muratore A, Massucco P, Siatis D, et al:
Genetic and expression analysis of MET, MACC1, and HGF in
metastatic colorectal cancer: Response to met inhibition in patient
xenografts and pathologic correlations. Clin Cancer Res.
17:3146–3156. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kobayashi S, Yamada-Okabe H, Suzuki M,
Natori O, Kato A, Matsubara K, Jau Chen Y, Yamazaki M, Funahashi S,
Yoshida K, et al: LGR5-positive colon cancer stem cells
inter-convert with drug-resistant LGR5-negative cells and are
capable of tumor reconstitution. Stem Cells. 30:2631–2644. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Scott CL, Becker MA, Haluska P and Samimi
G: Patient-derived xenograft models to improve targeted therapy in
epithelial ovarian cancer treatment. Front Oncol. 3:2952013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tokunaga T, Nakamura M, Oshika Y, Ohnishi
Y and Ueyama Y: Is xenotransplantability of human colon cancers in
SCID mice affected by angiogenic factors? J Natl Cancer Inst.
90:400–401. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dangles-Marie V, Pocard M, Richon S,
Weiswald LB, Assayag F, Saulnier P, Judde JG, Janneau JL, Auger N,
Validire P, et al: Establishment of human colon cancer cell lines
from fresh tumors versus xenografts: Comparison of success rate and
cell line features. Cancer Res. 67:398–407. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ito M, Hiramatsu H, Kobayashi K, Suzue K,
Kawahata M, Hioki K, Ueyama Y, Koyanagi Y, Sugamura K, Tsuji K, et
al: NOD/SCID/gamma(c)(null) mouse: An excellent recipient mouse
model for engraftment of human cells. Blood. 100:3175–3182. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Suemizu H, Monnai M, Ohnishi Y, Ito M,
Tamaoki N and Nakamura M: Identification of a key molecular
regulator of liver metastasis in human pancreatic carcinoma using a
novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG)
mice. Int J Oncol. 31:741–751. 2007.PubMed/NCBI
|
|
14
|
Chijiwa T, Abe Y, Ikoma N, Yamazaki H,
Tsukamoto H, Suemizu H, Kawai K, Wakui M, Nishime C, Matsumoto H,
et al: Thrombospondin 2 inhibits metastasis of human malignant
melanoma through microenvironment-modification in
NOD/SCID/gammaCnull (NOG) mice. Int J Oncol. 34:5–13. 2009.
|
|
15
|
Kubo A, Ohmura M, Wakui M, Harada T,
Kajihara S, Ogawa K, Suemizu H, Nakamura M, Setou M and Suematsu M:
Semi-quantitative analyses of metabolic systems of human colon
cancer metastatic xenografts in livers of superimmunodeficient NOG
mice. Anal Bioanal Chem. 400:1895–1904. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cho H, Watanabe T, Aoyama T, Hayashi T,
Yamada T, Ogata T, Yoshikawa T, Tsuburaya A, Sekiguchi H, Nakamura
Y, et al: Small bud of probable gastrointestinal stromal tumor
within a laparoscopically-resected gastric schwannoma. Int J Clin
Oncol. 17:294–298. 2012. View Article : Google Scholar
|
|
17
|
Yoshida T, Kinoshita H, Segawa T, Nakamura
E, Inoue T, Shimizu Y, Kamoto T and Ogawa O: Antiandrogen
bicalutamide promotes tumor growth in a novel androgen-dependent
prostate cancer xenograft model derived from a bicalutamide-treated
patient. Cancer Res. 65:9611–9616. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Marangoni E, Vincent-Salomon A, Auger N,
Degeorges A, Assayag F, de Cremoux P, de Plater L, Guyader C, De
Pinieux G, Judde JG, et al: A new model of patient tumor-derived
breast cancer xenografts for preclinical assays. Clin Cancer Res.
13:3989–3998. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mueller BM and Reisfeld RA: Potential of
the scid mouse as a host for human tumors. Cancer Metastasis Rev.
10:193–200. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bankert RB, Hess SD and Egilmez NK: SCID
mouse models to study human cancer pathogenesis and approaches to
therapy: Potential, limitations, and future directions. Front
Biosci. 7:c44–c62. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bibby MC: Orthotopic models of cancer for
preclinical drug evaluation: Advantages and disadvantages. Eur J
Cancer. 40:852–857. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Itoh T, Shiota M, Takanashi M, Hojo I,
Satoh H, Matsuzawa A, Moriyama T, Watanabe T, Hirai K and Mori S:
Engraftment of human non-Hodgkin lymphomas in mice with severe
combined immunodeficiency. Cancer. 72:2686–2694. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fujii E, Kato A, Chen YJ, Matsubara K,
Ohnishi Y and Suzuki M: Characterization of EBV-related
lymphoproliferative lesions arising in donor lymphocytes of
transplanted human tumor tissues in the NOG mouse. Exp Anim.
63:289–296. 2014. View Article : Google Scholar : PubMed/NCBI
|
